FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121166895> ?p ?o ?g. }

• W2121166895 abstract "A subgroup of the cholesterol-dependent cytolysin (CDC) family of pore-forming toxins (PFTs) has an unusually narrow host range due to a requirement for binding to human CD59 (hCD59), a glycosylphosphatidylinositol (GPI)-linked complement regulatory molecule. hCD59-specific CDCs are produced by several organisms that inhabit human mucosal surfaces and can act as pathogens, including Gardnerella vaginalis and Streptococcus intermedius. The consequences and potential selective advantages of such PFT host limitation have remained unknown. Here, we demonstrate that, in addition to species restriction, PFT ligation of hCD59 triggers a previously unrecognized pathway for programmed necrosis in primary erythrocytes (red blood cells [RBCs]) from humans and transgenic mice expressing hCD59. Because they lack nuclei and mitochondria, RBCs have typically been thought to possess limited capacity to undergo programmed cell death. RBC programmed necrosis shares key molecular factors with nucleated cell necroptosis, including dependence on Fas/FasL signaling and RIP1 phosphorylation, necrosome assembly, and restriction by caspase-8. Death due to programmed necrosis in RBCs is executed by acid sphingomyelinase-dependent ceramide formation, NADPH oxidase- and iron-dependent reactive oxygen species formation, and glycolytic formation of advanced glycation end products. Bacterial PFTs that are hCD59 independent do not induce RBC programmed necrosis. RBC programmed necrosis is biochemically distinct from eryptosis, the only other known programmed cell death pathway in mature RBCs. Importantly, RBC programmed necrosis enhances the growth of PFT-producing pathogens during exposure to primary RBCs, consistent with a role for such signaling in microbial growth and pathogenesis.In this work, we provide the first description of a new form of programmed cell death in erythrocytes (RBCs) that occurs as a consequence of cellular attack by human-specific bacterial toxins. By defining a new RBC death pathway that shares important components with necroptosis, a programmed necrosis module that occurs in nucleated cells, these findings expand our understanding of RBC biology and RBC-pathogen interactions. In addition, our work provides a link between cholesterol-dependent cytolysin (CDC) host restriction and promotion of bacterial growth in the presence of RBCs, which may provide a selective advantage to human-associated bacterial strains that elaborate such toxins and a potential explanation for the narrowing of host range observed in this toxin family." @default.
• W2121166895 created "2016-06-24" @default.
• W2121166895 creator A5015294970 @default.
• W2121166895 creator A5051304033 @default.
• W2121166895 creator A5051897918 @default.
• W2121166895 creator A5062265331 @default.
• W2121166895 creator A5067910050 @default.
• W2121166895 creator A5070712537 @default.
• W2121166895 creator A5090200098 @default.
• W2121166895 date "2014-10-31" @default.
• W2121166895 modified "2023-09-23" @default.
• W2121166895 title "Human-Specific Bacterial Pore-Forming Toxins Induce Programmed Necrosis in Erythrocytes" @default.
• W2121166895 cites W119125312 @default.
• W2121166895 cites W1523845694 @default.
• W2121166895 cites W1529252891 @default.
• W2121166895 cites W1688650085 @default.
• W2121166895 cites W1830721200 @default.
• W2121166895 cites W1938995264 @default.
• W2121166895 cites W1963877462 @default.
• W2121166895 cites W1979032223 @default.
• W2121166895 cites W1981794439 @default.
• W2121166895 cites W1996337519 @default.
• W2121166895 cites W2005252355 @default.
• W2121166895 cites W2006152878 @default.
• W2121166895 cites W2013376578 @default.
• W2121166895 cites W2016345107 @default.
• W2121166895 cites W2019471670 @default.
• W2121166895 cites W2028808853 @default.
• W2121166895 cites W2048305330 @default.
• W2121166895 cites W2052123857 @default.
• W2121166895 cites W2052605153 @default.
• W2121166895 cites W2060204808 @default.
• W2121166895 cites W2061361289 @default.
• W2121166895 cites W2080013385 @default.
• W2121166895 cites W2089626398 @default.
• W2121166895 cites W2089976554 @default.
• W2121166895 cites W2103264487 @default.
• W2121166895 cites W2104205504 @default.
• W2121166895 cites W2105430590 @default.
• W2121166895 cites W2113622325 @default.
• W2121166895 cites W2115652492 @default.
• W2121166895 cites W2121877228 @default.
• W2121166895 cites W2123109660 @default.
• W2121166895 cites W2123838494 @default.
• W2121166895 cites W2127073097 @default.
• W2121166895 cites W2129233971 @default.
• W2121166895 cites W2132161879 @default.
• W2121166895 cites W2132966139 @default.
• W2121166895 cites W2138787871 @default.
• W2121166895 cites W2139552156 @default.
• W2121166895 cites W2151229154 @default.
• W2121166895 cites W2158662692 @default.
• W2121166895 cites W2160651627 @default.
• W2121166895 cites W2161458210 @default.
• W2121166895 cites W2168477283 @default.
• W2121166895 cites W2317277068 @default.
• W2121166895 doi "https://doi.org/10.1128/mbio.01251-14" @default.
• W2121166895 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4173772" @default.
• W2121166895 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25161188" @default.
• W2121166895 hasPublicationYear "2014" @default.
• W2121166895 type Work @default.
• W2121166895 sameAs 2121166895 @default.
• W2121166895 citedByCount "40" @default.
• W2121166895 countsByYear W21211668952015 @default.
• W2121166895 countsByYear W21211668952016 @default.
• W2121166895 countsByYear W21211668952017 @default.
• W2121166895 countsByYear W21211668952018 @default.
• W2121166895 countsByYear W21211668952019 @default.
• W2121166895 countsByYear W21211668952020 @default.
• W2121166895 countsByYear W21211668952021 @default.
• W2121166895 countsByYear W21211668952022 @default.
• W2121166895 countsByYear W21211668952023 @default.
• W2121166895 crossrefType "journal-article" @default.
• W2121166895 hasAuthorship W2121166895A5015294970 @default.
• W2121166895 hasAuthorship W2121166895A5051304033 @default.
• W2121166895 hasAuthorship W2121166895A5051897918 @default.
• W2121166895 hasAuthorship W2121166895A5062265331 @default.
• W2121166895 hasAuthorship W2121166895A5067910050 @default.
• W2121166895 hasAuthorship W2121166895A5070712537 @default.
• W2121166895 hasAuthorship W2121166895A5090200098 @default.
• W2121166895 hasBestOaLocation W21211668951 @default.
• W2121166895 hasConcept C104317684 @default.
• W2121166895 hasConcept C17991360 @default.
• W2121166895 hasConcept C190283241 @default.
• W2121166895 hasConcept C203014093 @default.
• W2121166895 hasConcept C2777851122 @default.
• W2121166895 hasConcept C31573885 @default.
• W2121166895 hasConcept C503630168 @default.
• W2121166895 hasConcept C54355233 @default.
• W2121166895 hasConcept C55493867 @default.
• W2121166895 hasConcept C60987743 @default.
• W2121166895 hasConcept C66008609 @default.
• W2121166895 hasConcept C80595800 @default.
• W2121166895 hasConcept C86803240 @default.
• W2121166895 hasConcept C94030615 @default.
• W2121166895 hasConcept C95444343 @default.
• W2121166895 hasConceptScore W2121166895C104317684 @default.
• W2121166895 hasConceptScore W2121166895C17991360 @default.
• W2121166895 hasConceptScore W2121166895C190283241 @default.
• W2121166895 hasConceptScore W2121166895C203014093 @default.

• next